A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
Read more https://www.sciencedaily.com/releases/2025/02/250219134532.htm
A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
Read more https://www.sciencedaily.com/releases/2025/02/250219134532.htm